Xilio Therapeutics, Inc. - COM (XLO)

Historical Portfolio Holders from Q4 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
9.32 M
Holdings value Q1 2024
$10.1 M
Value change Q1 2024
-$2.78 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
26
Number of buys Q1 2024
9
Number of sells Q1 2024
-13
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
98422T100
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 9.32 M $10.1 M -$2.78 M $1.08 26
2023 Q4 14.8 M $8.15 M -$1.6 M $0.55 31
2023 Q3 15.9 M $33.5 M -$315 K $2.11 30
2023 Q2 16 M $41.9 M -$192 K $2.62 32
2023 Q1 16.1 M $51 M +$462 K $3.17 32
2022 Q4 15.9 M $42.8 M -$711 K $2.69 28
2022 Q3 16.6 M $48.2 M -$3.74 M $2.91 26
2022 Q2 17.8 M $52 M -$2.93 M $2.92 26
2022 Q1 18.8 M $133 M -$2.57 M $7.07 41
2021 Q4 19 M $303 M +$259 M $16.00 41